BioDrugs View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1997

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/40259

Recent publications latest 20 shown

  • 2019-04-10 Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab.
  • 2019-04-03 Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2-Biosimilar and Originator Etanercept in the Outpatient Setting.
  • 2019-04-03 Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1-Biosimilar and Originator Infliximab in the Hospital Setting.
  • 2019-04 First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors
  • 2019-04 A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males
  • 2019-04 PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen®): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers
  • 2019-04 LA-EP2006: A Pegfilgrastim Biosimilar
  • 2019-04 CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib
  • 2019-04 Vestronidase Alfa: A Review in Mucopolysaccharidosis VII
  • 2019-04 The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics
  • 2019-04 Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General Hospitals
  • 2019-04 In-Use Stability of the Rituximab Biosimilar CT-P10 (Truxima®) Following Preparation for Intravenous Infusion and Storage
  • 2019-04 Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA)
  • 2019-03-29 Physicochemical and Biological Characterization of RTXM83, a New Rituximab Biosimilar
  • 2019-03-21 PARP Inhibitors and the Evolving Landscape of Ovarian Cancer Management: A Review
  • 2019-02 Current Ebola Virus Vaccine Progress
  • 2019-02 Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
  • 2019-02 Comment on “The End of Phase 3 Clinical Trials in Biosimilars Development?”
  • 2019-02 Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
  • 2019-02 FKB327: An Adalimumab Biosimilar
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B1700X", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Molecular Medicine", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B14010", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Antibodies", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B11001", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Cancer Research", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H69000", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Pharmacotherapy", 
            "type": "DefinedTerm"
          }
        ], 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.108", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "1.038", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2017", 
            "ratingValue": "3.825", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "2.835", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "2.835", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "2.835", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "2.867", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "2.867", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "2.867", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "2.989", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "2.989", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "2.989", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "2.120", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "2.120", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "2.120", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "4.192", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "4.192", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "4.192", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "3.506", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "3.506", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "3.506", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "3.443", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "3.443", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "3.443", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "2.809", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "2.809", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "2.809", 
            "type": "Rating"
          }
        ], 
        "description": "

    An essential resource for R&D professionals and clinicians with an interest in biologic therapies.

    BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.

    BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal\u2019s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager\u00ae, supported by a database of international experts. This database is shared with other Adis journals.

    ", "editor": [ { "familyName": "Fraser", "givenName": "Kathy", "type": "Person" } ], "id": "sg:journal.1111842", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "1173-8804", "1179-190X" ], "license": "Hybrid (Open Choice)", "name": "BioDrugs", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "111842" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "40259" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "sn 97039188" ] }, { "name": "wos_id", "type": "PropertyValue", "value": [ "1173-8804/BIODRUGS" ] }, { "name": "scopus_id", "type": "PropertyValue", "value": [ "20051" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "9705305", "9430791" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "438428" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "14696" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1111842" ], "sdDataset": "journals", "sdDatePublished": "2021-01-19T05:00", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///pack/app/journals_20190313_sn_only.jsonl", "startYear": "1997", "type": "Periodical", "url": "http://link.springer.com/journal/40259" } ]

     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1111842'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1111842'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1111842'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1111842'


     

    This table displays all metadata directly associated to this object as RDF triples.

    264 TRIPLES      21 PREDICATES      59 URIs      51 LITERALS      38 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1111842 schema:about sg:ontologies/product-market-codes/B11001
    2 sg:ontologies/product-market-codes/B14010
    3 sg:ontologies/product-market-codes/B1700X
    4 sg:ontologies/product-market-codes/H69000
    5 schema:contentRating N0546448865ce45818876de4a3764322d
    6 N0fc8afa2f0f444eeafc726537f85a539
    7 N1b20b16b970d4964b42a116a4dc9f7f5
    8 N1dcac3e48fa140df97db714346d5b52b
    9 N33aeab9d98cd4b7aa188bf87df763504
    10 N4881238d25d446b9981d90ff31d3ece3
    11 N4ca3036279d94472b3615e94f3f46b0c
    12 N67c2e65716554a5a90a38e2546d93408
    13 N6ab3f2161bea4be686418956fcded2fe
    14 N729dccf4d9f44b32bea13621fbd72eb0
    15 N77ffc9e534c44dd8a62ffc77b6e8ce61
    16 N7b13f43e644f4395adaebd70534656e4
    17 N7bfbb7efb575424ab702064dd273028e
    18 N83fa4f8f7c534fde85b89b0b9e4d13f5
    19 N8ae2d81f3d1f497e840eaf0386792944
    20 N8fa9c1b7acc44510ac7df1c1636093f9
    21 N92e1b0c1bc8b47628f5c2d1f0e0aa790
    22 N9cc005b08bbb4718af76bc06f72373b0
    23 Nb5aaecfc88cb4a8a97ae3a313af9ef98
    24 Nb85c746b62ea4922b294c3812b96afaa
    25 Nd803beac67a34b0e8e04bce0293746be
    26 Ndad67775a4204562bedd3a26bc7ef288
    27 Ndcd4159f424b452f8b92e2ea180de8c2
    28 Ne27246fe20d141258bdcde0013b2a819
    29 Neaf2e46ef5d44b71ba397bbc2b274ec9
    30 Nf5bb7adda84a4f7880012f95e3534236
    31 Nfffabdfd0ffa4c68af5e81dd4e848c58
    32 schema:description <p>An essential resource for R&amp;D professionals and clinicians with an interest in biologic therapies.</p><p><i>BioDrugs</i> covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease<b>.</b></p><p><i>BioDrugs</i> offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.</p><p/>
    33 schema:editor N03593ab55ab042469563bda05abf1c61
    34 schema:inLanguage en
    35 schema:isAccessibleForFree false
    36 schema:issn 1173-8804
    37 1179-190X
    38 schema:license Hybrid (Open Choice)
    39 schema:name BioDrugs
    40 schema:productId N2896b1b7e6474c45ba553914ffdfa84a
    41 N3ab6e9ad09ac477d84b879f88624966a
    42 N822764fe28ad427a9b099367058114ff
    43 N831a603025d64538a18cbd776d2b9d80
    44 N8e1d804d9eba4147ab03070ca58d365f
    45 Nc026ced7d91a4f359546b6f21680ec66
    46 Nf630e17a02c647219a0bca1c0c161db3
    47 Nf85fb7c8e81b49b19849299f88e626e7
    48 schema:publisher N151f7662cac04d37a4d13be53353235a
    49 schema:publisherImprint Adis
    50 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1111842
    51 schema:sdDatePublished 2021-01-19T05:00
    52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    53 schema:sdPublisher N670eb6962bec4aaf926c0f90ac8e8fcd
    54 schema:startYear 1997
    55 schema:url http://link.springer.com/journal/40259
    56 sgo:license sg:explorer/license/
    57 sgo:sdDataset journals
    58 rdf:type schema:Periodical
    59 N03593ab55ab042469563bda05abf1c61 rdf:first N3dae7ad62f114c808f258b1c11fabedd
    60 rdf:rest rdf:nil
    61 N0546448865ce45818876de4a3764322d schema:author N9759f0638e314474acdd5b5c2bfb2b53
    62 schema:dateCreated 2011
    63 schema:ratingValue 3.443
    64 rdf:type schema:Rating
    65 N0fc8afa2f0f444eeafc726537f85a539 schema:author Nb35aeba1781343dcb38d66a1ed4fc0b7
    66 schema:dateCreated 2016
    67 schema:ratingValue 2.835
    68 rdf:type schema:Rating
    69 N151f7662cac04d37a4d13be53353235a schema:name Springer International Publishing
    70 rdf:type schema:Organization
    71 N1b20b16b970d4964b42a116a4dc9f7f5 schema:author Na96d8651a7d54711b237fe138a0a04ee
    72 schema:ratingValue 1.038
    73 rdf:type schema:Rating
    74 N1dcac3e48fa140df97db714346d5b52b schema:author N93483146b736468c80f1f1ed5ea81efb
    75 schema:dateCreated 2012
    76 schema:ratingValue 2.809
    77 rdf:type schema:Rating
    78 N2896b1b7e6474c45ba553914ffdfa84a schema:name era_ids_id
    79 schema:value 14696
    80 rdf:type schema:PropertyValue
    81 N33aeab9d98cd4b7aa188bf87df763504 schema:author N579d5880edef479196f9e02af252fe95
    82 schema:dateCreated 2011
    83 schema:ratingValue 3.443
    84 rdf:type schema:Rating
    85 N3ab6e9ad09ac477d84b879f88624966a schema:name nsd_ids_id
    86 schema:value 438428
    87 rdf:type schema:PropertyValue
    88 N3dae7ad62f114c808f258b1c11fabedd schema:familyName Fraser
    89 schema:givenName Kathy
    90 rdf:type schema:Person
    91 N3e3d2612ae484c989dd5523226194ccf rdf:first impact_factor_wos
    92 rdf:rest rdf:nil
    93 N3e704764b5244d1380c70733c1acfee7 rdf:first impact_factor_wos
    94 rdf:rest rdf:nil
    95 N440e5190c39a4212b180aa2cc4d9fc18 rdf:first impact_factor_wos
    96 rdf:rest rdf:nil
    97 N4881238d25d446b9981d90ff31d3ece3 schema:author Nc462e1124d2648daa5ac9f596963b89f
    98 schema:dateCreated 2013
    99 schema:ratingValue 2.120
    100 rdf:type schema:Rating
    101 N4ca3036279d94472b3615e94f3f46b0c schema:author Ndf545f5eaa3042c08851eb52d4fcc600
    102 schema:dateCreated 2013
    103 schema:ratingValue 2.120
    104 rdf:type schema:Rating
    105 N52ea85522486443ba98c31c12c336246 rdf:first impact_factor_wos
    106 rdf:rest rdf:nil
    107 N579d5880edef479196f9e02af252fe95 rdf:first impact_factor_wos
    108 rdf:rest rdf:nil
    109 N59d6268da55d4b0aa2146996ca636286 rdf:first impact_factor_wos
    110 rdf:rest rdf:nil
    111 N5dafe463b77f4f5c84629a7d54f37ce5 rdf:first impact_factor_wos
    112 rdf:rest rdf:nil
    113 N670eb6962bec4aaf926c0f90ac8e8fcd schema:name Springer Nature - SN SciGraph project
    114 rdf:type schema:Organization
    115 N67c2e65716554a5a90a38e2546d93408 schema:author Ne47af0cf25254987835869863b3a2510
    116 schema:dateCreated 2009
    117 schema:ratingValue 3.506
    118 rdf:type schema:Rating
    119 N6ab3f2161bea4be686418956fcded2fe schema:author Nd57c5b21f58e4243b6607c437ffdd8ed
    120 schema:dateCreated 2015
    121 schema:ratingValue 2.867
    122 rdf:type schema:Rating
    123 N729dccf4d9f44b32bea13621fbd72eb0 schema:author N5dafe463b77f4f5c84629a7d54f37ce5
    124 schema:dateCreated 2010
    125 schema:ratingValue 4.192
    126 rdf:type schema:Rating
    127 N77311ad4cf954ea88bb6949eb51d9d5f rdf:first impact_factor_wos
    128 rdf:rest rdf:nil
    129 N77ffc9e534c44dd8a62ffc77b6e8ce61 schema:author N52ea85522486443ba98c31c12c336246
    130 schema:dateCreated 2016
    131 schema:ratingValue 2.835
    132 rdf:type schema:Rating
    133 N7b13f43e644f4395adaebd70534656e4 schema:author N440e5190c39a4212b180aa2cc4d9fc18
    134 schema:dateCreated 2015
    135 schema:ratingValue 2.867
    136 rdf:type schema:Rating
    137 N7bfbb7efb575424ab702064dd273028e schema:author N77311ad4cf954ea88bb6949eb51d9d5f
    138 schema:dateCreated 2010
    139 schema:ratingValue 4.192
    140 rdf:type schema:Rating
    141 N7caef5a3b220440088825e48713c0925 rdf:first impact_factor_wos
    142 rdf:rest rdf:nil
    143 N822764fe28ad427a9b099367058114ff schema:name springer_id
    144 schema:value 40259
    145 rdf:type schema:PropertyValue
    146 N831a603025d64538a18cbd776d2b9d80 schema:name scopus_id
    147 schema:value 20051
    148 rdf:type schema:PropertyValue
    149 N83fa4f8f7c534fde85b89b0b9e4d13f5 schema:author N3e704764b5244d1380c70733c1acfee7
    150 schema:dateCreated 2011
    151 schema:ratingValue 3.443
    152 rdf:type schema:Rating
    153 N8ae2d81f3d1f497e840eaf0386792944 schema:author Nbecd0331e8f14a7994332d0789ed5cbc
    154 schema:dateCreated 2015
    155 schema:ratingValue 2.867
    156 rdf:type schema:Rating
    157 N8e1d804d9eba4147ab03070ca58d365f schema:name dimensions_id
    158 schema:value 111842
    159 rdf:type schema:PropertyValue
    160 N8fa9c1b7acc44510ac7df1c1636093f9 schema:author N3e3d2612ae484c989dd5523226194ccf
    161 schema:dateCreated 2017
    162 schema:ratingValue 3.825
    163 rdf:type schema:Rating
    164 N92e1b0c1bc8b47628f5c2d1f0e0aa790 schema:author Nf626d1fc95f84a2bbd06fcc9720d37e2
    165 schema:dateCreated 2012
    166 schema:ratingValue 2.809
    167 rdf:type schema:Rating
    168 N93483146b736468c80f1f1ed5ea81efb rdf:first impact_factor_wos
    169 rdf:rest rdf:nil
    170 N9759f0638e314474acdd5b5c2bfb2b53 rdf:first impact_factor_wos
    171 rdf:rest rdf:nil
    172 N9cc005b08bbb4718af76bc06f72373b0 schema:author Nb06936e4168943eb909fdc757135aa2a
    173 schema:dateCreated 2009
    174 schema:ratingValue 3.506
    175 rdf:type schema:Rating
    176 N9d4400a190704d7ca4774ffaf2d6612f rdf:first impact_factor_wos
    177 rdf:rest rdf:nil
    178 N9eb9ff72daf04c14af20f536ae14962d rdf:first impact_factor_wos
    179 rdf:rest rdf:nil
    180 Na96d8651a7d54711b237fe138a0a04ee rdf:first sjr
    181 rdf:rest rdf:nil
    182 Naaaf220834754fbe965c1130146ea598 rdf:first impact_factor_wos
    183 rdf:rest rdf:nil
    184 Nb06936e4168943eb909fdc757135aa2a rdf:first impact_factor_wos
    185 rdf:rest rdf:nil
    186 Nb35aeba1781343dcb38d66a1ed4fc0b7 rdf:first impact_factor_wos
    187 rdf:rest rdf:nil
    188 Nb5aaecfc88cb4a8a97ae3a313af9ef98 schema:author Nefc0b892b7c9424dbc4735e5eeb3a9f4
    189 schema:dateCreated 2014
    190 schema:ratingValue 2.989
    191 rdf:type schema:Rating
    192 Nb85c746b62ea4922b294c3812b96afaa schema:author N9d4400a190704d7ca4774ffaf2d6612f
    193 schema:dateCreated 2014
    194 schema:ratingValue 2.989
    195 rdf:type schema:Rating
    196 Nbecd0331e8f14a7994332d0789ed5cbc rdf:first impact_factor_wos
    197 rdf:rest rdf:nil
    198 Nc026ced7d91a4f359546b6f21680ec66 schema:name wos_id
    199 schema:value 1173-8804/BIODRUGS
    200 rdf:type schema:PropertyValue
    201 Nc1eb5531db9f420a9fc7fed569ec37bc rdf:first impact_factor_wos
    202 rdf:rest rdf:nil
    203 Nc462e1124d2648daa5ac9f596963b89f rdf:first impact_factor_wos
    204 rdf:rest rdf:nil
    205 Nd57c5b21f58e4243b6607c437ffdd8ed rdf:first impact_factor_wos
    206 rdf:rest rdf:nil
    207 Nd803beac67a34b0e8e04bce0293746be schema:author Nc1eb5531db9f420a9fc7fed569ec37bc
    208 schema:dateCreated 2012
    209 schema:ratingValue 2.809
    210 rdf:type schema:Rating
    211 Ndad67775a4204562bedd3a26bc7ef288 schema:author N59d6268da55d4b0aa2146996ca636286
    212 schema:dateCreated 2013
    213 schema:ratingValue 2.120
    214 rdf:type schema:Rating
    215 Ndcd4159f424b452f8b92e2ea180de8c2 schema:author N7caef5a3b220440088825e48713c0925
    216 schema:dateCreated 2014
    217 schema:ratingValue 2.989
    218 rdf:type schema:Rating
    219 Ndf545f5eaa3042c08851eb52d4fcc600 rdf:first impact_factor_wos
    220 rdf:rest rdf:nil
    221 Ne27246fe20d141258bdcde0013b2a819 schema:author Nfc30619fc5574e55bc411fca40492324
    222 schema:dateCreated 2016
    223 schema:ratingValue 2.835
    224 rdf:type schema:Rating
    225 Ne47af0cf25254987835869863b3a2510 rdf:first impact_factor_wos
    226 rdf:rest rdf:nil
    227 Neaf2e46ef5d44b71ba397bbc2b274ec9 schema:author Naaaf220834754fbe965c1130146ea598
    228 schema:dateCreated 2009
    229 schema:ratingValue 3.506
    230 rdf:type schema:Rating
    231 Nefc0b892b7c9424dbc4735e5eeb3a9f4 rdf:first impact_factor_wos
    232 rdf:rest rdf:nil
    233 Nf5bb7adda84a4f7880012f95e3534236 schema:author N9eb9ff72daf04c14af20f536ae14962d
    234 schema:dateCreated 2010
    235 schema:ratingValue 4.192
    236 rdf:type schema:Rating
    237 Nf626d1fc95f84a2bbd06fcc9720d37e2 rdf:first impact_factor_wos
    238 rdf:rest rdf:nil
    239 Nf630e17a02c647219a0bca1c0c161db3 schema:name nlm_unique_id
    240 schema:value 9430791
    241 9705305
    242 rdf:type schema:PropertyValue
    243 Nf85fb7c8e81b49b19849299f88e626e7 schema:name lccn_id
    244 schema:value sn 97039188
    245 rdf:type schema:PropertyValue
    246 Nfc30619fc5574e55bc411fca40492324 rdf:first impact_factor_wos
    247 rdf:rest rdf:nil
    248 Nfeb521e370864f03bed4d21720f4ac5e rdf:first snip
    249 rdf:rest rdf:nil
    250 Nfffabdfd0ffa4c68af5e81dd4e848c58 schema:author Nfeb521e370864f03bed4d21720f4ac5e
    251 schema:ratingValue 1.108
    252 rdf:type schema:Rating
    253 sg:ontologies/product-market-codes/B11001 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    254 schema:name Cancer Research
    255 rdf:type schema:DefinedTerm
    256 sg:ontologies/product-market-codes/B14010 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    257 schema:name Antibodies
    258 rdf:type schema:DefinedTerm
    259 sg:ontologies/product-market-codes/B1700X schema:inDefinedTermSet sg:ontologies/product-market-codes/
    260 schema:name Molecular Medicine
    261 rdf:type schema:DefinedTerm
    262 sg:ontologies/product-market-codes/H69000 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    263 schema:name Pharmacotherapy
    264 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...